Silva Pharmaceuticals Limited announced audited earnings results for the year ended June 30, 2018. For the year, the company announced profit after tax was BDT 92.99 million and basic EPS was BDT 0.93 as against profit after tax of BDT 80.28 million and basic EPS of BDT 1.03 for the previous year ended on 30 June 2017. However, Post-IPO basic EPS for the year ended on 30 June 2018 would be BDT 0.72. (cont.) (Continuation news of SILVAPHL): On the other hand, NAV per share (considering Pre-IPO paid up shares) was BDT 17.11 as on 30 June 2018 and the same would be BDT 15.47 (considering Post-IPO paid up shares).